» Articles » PMID: 22491862

Influence of Pregnancy on Neuromyelitis Optica Spectrum Disorder

Overview
Journal Neurology
Specialty Neurology
Date 2012 Apr 12
PMID 22491862
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the influence of pregnancy on patients with neuromyelitis optica spectrum disorder (NMOSD).

Methods: A total of 190 women with NMOSD were enrolled from 7 referral hospitals in 4 countries. We reviewed medical records and used a structured questionnaire to investigate gravidity, parity, and the number of relapses during the 2 years before pregnancy, during each trimester of pregnancy, during the first and second trimesters after delivery, and for 6 months thereafter. The annualized relapse rate (ARR) was calculated for each period.

Results: Of the 190 women with NMOSD, 40 patients experienced 54 informative pregnancies, and all of them were seropositive for aquaporin-4 antibody. Fourteen patients developed the first symptoms of NMOSD either during the pregnancy (3 patients) or within a year after delivery or abortion (8 and 3 patients, respectively). Twenty-six patients experienced 40 pregnancies after the onset of NMOSD (26 deliveries and 14 abortions [1 spontaneous and 13 elective]). There was one preterm delivery with birth defects and no stillbirths. The ARR during pregnancy did not differ from that before pregnancy, but it increased significantly during the first and second trimesters after delivery (5.3 and 3.7 times, respectively). Moreover, 77% of the deliveries were associated with postpartum relapses.

Conclusion: The significantly increased relapse rate and numerous cases of NMOSD onset after pregnancy suggest that delivery adversely affects the course of NMOSD. Prospective studies are needed to confirm our findings.

Citing Articles

Insights into neuromyelitis optica spectrum disorder and pregnancy from a single-center study in Thailand.

Budtarad N, Ongphichetmehta T, Siritho S Sci Rep. 2025; 15(1):4011.

PMID: 39893222 PMC: 11787356. DOI: 10.1038/s41598-025-88624-x.


Pregnancy characteristics in Egyptian female patients with NMOSD.

Gad A, Kishk N, Shalaby N, Heikal E, Fouad A, Merghany N Mult Scler J Exp Transl Clin. 2024; 10(3):20552173241271878.

PMID: 39139781 PMC: 11320409. DOI: 10.1177/20552173241271878.


Lactational optic neuritis - A case series with review of the literature.

Chaudhary S, Gandhi A, Das S, Jayasri K, Maheshkumar S, Kowsalya A Indian J Ophthalmol. 2024; 72(11):1593-1597.

PMID: 38622848 PMC: 11668224. DOI: 10.4103/IJO.IJO_2133_23.


Sex hormones and neuromyelitis optica spectrum disorder: a bidirectional Mendelian randomization study.

Hu Y, Zou F, Lu W Neurol Sci. 2024; 45(9):4471-4479.

PMID: 38565746 DOI: 10.1007/s10072-024-07501-z.


Efficacy and safety of monoclonal antibodies in neuromyelitis optica spectrum disorders: A survival meta-analysis of randomized controlled trials.

Xu X, Xie L, Wei L, Li M, Wang H, Zhou H Adv Ophthalmol Pract Res. 2023; 2(3):100064.

PMID: 37846287 PMC: 10577852. DOI: 10.1016/j.aopr.2022.100064.